Nov 2 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
BONEH.HE :
* BBS-BIOACTIVE BONE SUBSTITUTES OYJ - INFORMED BY NOTIFIED
BODY
THAT FINAL APPROVAL OF QUALITY SYSTEM IS EXPECTED WITHIN
APPROXIMATELY ONE MONTH
* BBS-BIOACTIVE BONE SUBSTITUTES OYJ - CO'S GUIDANCE ON
OVERALL
SCHEDULE FOR CE MARKING REMAINS UNCHANGED
* BBS-BIOACTIVE BONE SUBSTITUTES - FOLLOWING QUALITY SYSTEM
APPROVAL, PRODUCT APPROVAL IS NEXT, PART OF WHICH IS
CONSULTATION WITH FINNISH MEDICINES AGENCY
* BBS-BIOACTIVE BONE SUBSTITUTES - CONSULTATION WITH FIMEA
IS PART
OF OFFICIAL CE MARKING PROCESS ;CO EXPECTS CONSULTATION TO TAKE
3-7 MONTHS TO BE COMPLETED
* BBS-BIOACTIVE BONE SUBSTITUTES OYJ - NOTIFIED BODY HAS
INFORMED
COMPANY ON 2 NOVEMBER 2023 THAT CONSULTATION WILL BEGIN ON 21
NOVEMBER 2023
Source text for Eikon: ID:nGNE5ymPG4
Further company coverage: BONEH.HE
((Reuters.Briefs@thomsonreuters.com;))